The human ether-à-go-go related gene (hERG) inhibition at 1uM of a drug with the SMILES CN1CCN(CC(=O)N(Cc2c(C#N)c3ccccc3n2C)c2ccccc2)CC1 is 3.101\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CN1CCN(CC(=O)N(Cc2c(C#N)c3ccccc3n2C)c2ccccc2)CC1
CN1CCN(CC(=O)N(Cc2c(C#N)c3ccccc3n2C)c2ccccc2)CC1
[C][N][C][C][N][Branch2][Ring2][Branch1][C][C][=Branch1][C][=O][N][Branch2][Ring1][Ring2][C][C][=C][Branch1][Ring1][C][#N][C][=C][C][=C][C][=C][Ring1][=Branch1][N][Ring1][O][C][C][=C][C][=C][C][=C][Ring1][=Branch1][C][C][Ring2][Ring1][=N]
N-[(3-cyano-1-methylindol-2-yl)methyl]-2-(4-methylpiperazin-1-yl)-N-phenylacetamide